ERVW-1 and neoplasm: In a mouse xenograft study, it was found that T cells genetically engineered to target the ERVK Env protein were able to exert significant anti-tumor effects on metastasized melanoma tumors expressing the ERVK Env in an antigen-specific fashion (Krishnamurthy et al., 2015).